Hyfinity Investments
11
24M
11
4
- Areas of investment
Summary
The company was established in Asia in China. The main office of represented VC is situated in the Chaoyang.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Robotics, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Hexaell Biotech.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019.
The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Tencent Holdings, Shunwei Capital, ShenZhen GTJA Investment Group.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 4
- Investments by industry
- Biotechnology (7)
- Medical (6)
- Health Care (6)
- Pharmaceutical (3)
- Biopharma (2) Show 4 more
- Investments by region
-
- China (7)
- Iceland (1)
- United States (1)
- Singapore (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.82
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Delova Biotech | 02 Apr 2024 | Biotechnology, Health Care, Medical | Early Stage Venture | 15M | |
| Surgerii Technology | 26 Feb 2019 | Robotics, Medical | Early Stage Venture | 0 | China, Beijing, Haidian District |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.